Promising anti-SARS-CoV-2 drugs by effective dual targeting against the viral and host proteases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Promising anti-SARS-CoV-2 drugs by effective dual targeting against the viral and host proteases
Authors
Keywords
SARS-CoV-2, COVID-19, Dual antiviral activity, Anti-M, Anti-PLpro, Anti-furin
Journal
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 43, Issue -, Pages 128099
Publisher
Elsevier BV
Online
2021-05-10
DOI
10.1016/j.bmcl.2021.128099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
- (2021) Chun-Hui Zhang et al. ACS Central Science
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics
- (2020) Jinnong Zhang et al. Lancet Respiratory Medicine
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade
- (2020) B. Coutard et al. ANTIVIRAL RESEARCH
- Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
- (2020) Arun K. Ghosh et al. ChemMedChem
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Drug treatment options for the 2019-new coronavirus (2019-nCoV)
- (2020) Hongzhou Lu BioScience Trends
- Homology modeling and in silico design of novel and potential dual-acting inhibitors of human histone deacetylases HDAC5 and HDAC9 isozymes
- (2020) Ammar D. Elmezayen et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- The SARS-CoV-2 main protease as drug target
- (2020) Sven Ullrich et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
- (2020) Ahmed Mostafa et al. Pharmaceuticals
- Protective role for the N-terminal domain of α-dystroglycan in Influenza A virus proliferation
- (2019) Jessica C. de Greef et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy
- (2019) Xiaojing Shi et al. MOLECULAR THERAPY
- Development and Testing of Druglike Screening Libraries
- (2018) Junmei Wang et al. Journal of Chemical Information and Modeling
- Proteases and protease inhibitors in infectious diseases
- (2017) Ayodeji A. Agbowuro et al. MEDICINAL RESEARCH REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started